User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Primary tabs

download
  • Open access
  • PDF
  • 2.41 M
download
  • Open access
  • PDF
  • 509.61 K
Depommier, Clara [UCL] Everard, Amandine [UCL] Druart, Céline [UCL] Plovier, Hubert [UCL] Van Hul, Matthias [UCL] Maiter, Dominique [UCL] Delzenne, Nathalie M. [UCL] de Barsy, Marie [UCL] Loumaye, Audrey [UCL] Hermans, Michel [UCL] Thissen, Jean-Paul [UCL] Cani, Patrice D. [UCL]

Metabolic syndrome is characterized by a constellation of comorbidities that predispose individuals to an increased risk of developing cardiovascular pathologies as well as type 2 diabetes mellitus. The gut microbiota is a new key contributor involved in the onset of obesity-related disorders. In humans, studies have provided evidence for a negative correlation between Akkermansia muciniphila abundance and overweight, obesity, untreated type 2 diabetes mellitus or hypertension. Since the administration of A. muciniphila has never been investigated in humans, we conducted a randomized, double-blind, placebo-controlled pilot study in overweight/obese insulin-resistant volunteers; 40 were enrolled and 32 completed the trial. The primary end points were safety, tolerability and metabolic parameters (that is, insulin resistance, circulating lipids, visceral adiposity and body mass). Secondary outcomes were gut barrier function (that is, plasma lipopolysaccharides) and gut microbiota composition. In this single-center study, we demonstrated that daily oral supplementation of 10 A. muciniphila bacteria either live or pasteurized for three months was safe and well tolerated. Compared to placebo, pasteurized A. muciniphila improved insulin sensitivity (+28.62 ± 7.02%, P = 0.002), and reduced insulinemia (-34.08 ± 7.12%, P = 0.006) and plasma total cholesterol (-8.68 ± 2.38%, P = 0.02). Pasteurized A. muciniphila supplementation slightly decreased body weight (-2.27 ± 0.92 kg, P = 0.091) compared to the placebo group, and fat mass (-1.37 ± 0.82 kg, P = 0.092) and hip circumference (-2.63 ± 1.14 cm, P = 0.091) compared to baseline. After three months of supplementation, A. muciniphila reduced the levels of the relevant blood markers for liver dysfunction and inflammation while the overall gut microbiome structure was unaffected. In conclusion, this proof-of-concept study (clinical trial no. NCT02637115 ) shows that the intervention was safe and well tolerated and that supplementation with A. muciniphila improves several metabolic parameters.

Document type Article de périodique (Journal article) – Lettre à l'éditeur
Access type Accès libre
Publication date 2019
Language Anglais
Journal information "Nature medicine" - Vol. 25, no.7, p. 1096-1103 (2019)
Peer reviewed yes
Publisher Nature Publishing Company ((United States) New York, NY)
issn 1078-8956
e-issn 1546-170X
Publication status Publié
Affiliations UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition
UCL - SSS/LDRI - Louvain Drug Research Institute
UCL - (SLuc) Service d'endocrinologie et de nutrition
Links
  1. O'Neill S., O'Driscoll L., Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies : Metabolic syndrome, 10.1111/obr.12229
  2. Cani Patrice D., Van Hul Matthias, Lefort Charlotte, Depommier Clara, Rastelli Marialetizia, Everard Amandine, Microbial regulation of organismal energy homeostasis, 10.1038/s42255-018-0017-4
  3. Brahe L K, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich S D, Larsen L H, Specific gut microbiota features and metabolic markers in postmenopausal women with obesity, 10.1038/nutd.2015.9
  4. Zhang Xiuying, Shen Dongqian, Fang Zhiwei, Jie Zhuye, Qiu Xinmin, Zhang Chunfang, Chen Yingli, Ji Linong, Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance, 10.1371/journal.pone.0071108
  5. Yassour Moran, Lim Mi Young, Yun Hyun Sun, Tickle Timothy L., Sung Joohon, Song Yun-Mi, Lee Kayoung, Franzosa Eric A., Morgan Xochitl C., Gevers Dirk, Lander Eric S., Xavier Ramnik J., Birren Bruce W., Ko GwangPyo, Huttenhower Curtis, Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes, 10.1186/s13073-016-0271-6
  6. Li Jing, Zhao Fangqing, Wang Yidan, Chen Junru, Tao Jie, Tian Gang, Wu Shouling, Liu Wenbin, Cui Qinghua, Geng Bin, Zhang Weili, Weldon Ryan, Auguste Kelda, Yang Lei, Liu Xiaoyan, Chen Li, Yang Xinchun, Zhu Baoli, Cai Jun, Gut microbiota dysbiosis contributes to the development of hypertension, 10.1186/s40168-016-0222-x
  7. Liu Ruixin, Hong Jie, Xu Xiaoqiang, Feng Qiang, Zhang Dongya, Gu Yanyun, Shi Juan, Zhao Shaoqian, Liu Wen, Wang Xiaokai, Xia Huihua, Liu Zhipeng, Cui Bin, Liang Peiwen, Xi Liuqing, Jin Jiabin, Ying Xiayang, Wang Xiaolin, Zhao Xinjie, Li Wanyu, Jia Huijue, Lan Zhou, Li Fengyu, Wang Rui, Sun Yingkai, Yang Minglan, Shen Yuxin, Jie Zhuye, Li Junhua, Chen Xiaomin, Zhong Huanzi, Xie Hailiang, Zhang Yifei, Gu Weiqiong, Deng Xiaxing, Shen Baiyong, Xu Xun, Yang Huanming, Xu Guowang, Bi Yufang, Lai Shenghan, Wang Jian, Qi Lu, Madsen Lise, Wang Jiqiu, Ning Guang, Kristiansen Karsten, Wang Weiqing, Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention, 10.1038/nm.4358
  8. Dao Maria Carlota, Everard Amandine, Aron-Wisnewsky Judith, Sokolovska Nataliya, Prifti Edi, Verger Eric O, Kayser Brandon D, Levenez Florence, Chilloux Julien, Hoyles Lesley, Dumas Marc-Emmanuel, Rizkalla Salwa W, Doré Joel, Cani Patrice D, Clément Karine, , Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, 10.1136/gutjnl-2014-308778
  9. Cani Patrice D., de Vos Willem M., Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila, 10.3389/fmicb.2017.01765
  10. Everard A., Belzer C., Geurts L., Ouwerkerk J. P., Druart C., Bindels L. B., Guiot Y., Derrien M., Muccioli G. G., Delzenne N. M., de Vos W. M., Cani P. D., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, 10.1073/pnas.1219451110
  11. Plovier Hubert, Everard Amandine, Druart Céline, Depommier Clara, Van Hul Matthias, Geurts Lucie, Chilloux Julien, Ottman Noora, Duparc Thibaut, Lichtenstein Laeticia, Myridakis Antonis, Delzenne Nathalie M, Klievink Judith, Bhattacharjee Arnab, van der Ark Kees C H, Aalvink Steven, Martinez Laurent O, Dumas Marc-Emmanuel, Maiter Dominique, Loumaye Audrey, Hermans Michel P, Thissen Jean-Paul, Belzer Clara, de Vos Willem M, Cani Patrice D, A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, 10.1038/nm.4236
  12. Everard Amandine, Plovier Hubert, Rastelli Marialetizia, Van Hul Matthias, de Wouters d’Oplinter Alice, Geurts Lucie, Druart Céline, Robine Sylvie, Delzenne Nathalie M., Muccioli Giulio G., de Vos Willem M., Luquet Serge, Flamand Nicolas, Di Marzo Vincenzo, Cani Patrice D., Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis, 10.1038/s41467-018-08051-7
  13. Atkin Stephen L., Katsiki Niki, Banach Maciej, Mikhailidis Dimitri P., Pirro Matteo, Sahebkar Amirhossein, Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials, 10.1016/j.jdiacomp.2017.05.016
  14. Akoumianakis Ioannis, Antoniades Charalambos, Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease, 10.1016/j.vph.2017.07.001
  15. Olivares Marta, Schüppel Valentina, Hassan Ahmed M., Beaumont Martin, Neyrinck Audrey M., Bindels Laure B., Benítez-Páez Alfonso, Sanz Yolanda, Haller Dirk, Holzer Peter, Delzenne Nathalie M., The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health, 10.3389/fmicb.2018.01900
  16. Veronelli A., Laneri M., Ranieri R., Koprivec D., Vardaro D., Paganelli M., Folli F., Pontiroli A. E., White Blood Cells in Obesity and Diabetes: Effects of weight loss and normalization of glucose metabolism, 10.2337/diacare.27.10.2501
  17. Ohshita K., Yamane K., Hanafusa M., Mori H., Mito K., Okubo M., Hara H., Kohno N., Elevated White Blood Cell Count in Subjects With Impaired Glucose Tolerance, 10.2337/diacare.27.2.491
  18. Gu Yeqing, Hu Kuiru, Huang Yuhan, Zhang Qing, Liu Li, Meng Ge, Wu Hongmei, Xia Yang, Bao Xue, Shi Hongbin, Wang Honglei, Sun Shaomei, Wang Xing, Zhou Ming, Jia Qiyu, Song Kun, Niu Kaijun, White blood cells count as an indicator to identify whether obesity leads to increased risk of type 2 diabetes, 10.1016/j.diabres.2018.04.041
  19. Zhang Hongmei, Yang Zhen, Zhang Weiwei, Niu Yixin, Li Xiaoyong, Qin Li, Su Qing, White blood cell subtypes and risk of type 2 diabetes, 10.1016/j.jdiacomp.2016.10.029
  20. Twig G., Afek A., Shamiss A., Derazne E., Tzur D., Gordon B., Tirosh A., White Blood Cells Count and Incidence of Type 2 Diabetes in Young Men, 10.2337/dc11-2298
  21. Shen Jing, Tong Xuedong, Sud Neetu, Khound Rituraj, Song Yongyan, Maldonado-Gomez Maria X., Walter Jens, Su Qiaozhu, Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced Hyperlipidemia, 10.1161/atvbaha.116.307597
  22. Li Jin, Lin Shaoqiang, Vanhoutte Paul M., Woo Connie W., Xu Aimin, Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice, 10.1161/circulationaha.115.019645
  23. Ras Rouyanne T., Hiemstra Harry, Lin Yuguang, Vermeer Mario A., Duchateau Guus S.M.J.E., Trautwein Elke A., Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations – A meta-analysis of randomized controlled studies, 10.1016/j.atherosclerosis.2013.08.012
  24. Wannamethee S. G., Shaper A. G., Lennon L., Whincup P. H., Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men, 10.2337/diacare.28.12.2913
  25. Rantala A. O., Lilja M., Kauma H., Savolainen M. J., Reunanen A., Kesaniemi Y. A., Gamma-glutamyl transpeptidase and the metabolic syndrome, 10.1046/j.1365-2796.2000.00723.x
  26. Lim J.-S., Lee D.-H., Park J.-Y., Jin S.-H., Jacobs D. R., A Strong Interaction between Serum  -Glutamyltransferase and Obesity on the Risk of Prevalent Type 2 Diabetes: Results from the Third National Health and Nutrition Examination Survey, 10.1373/clinchem.2006.079814
  27. Fraser A., Harris R., Sattar N., Ebrahim S., Davey Smith G., Lawlor D. A., Alanine Aminotransferase,  -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis, 10.2337/dc08-1870
  28. Hänninen Arno, Toivonen Raine, Pöysti Sakari, Belzer Clara, Plovier Hubert, Ouwerkerk Janneke P, Emani Rohini, Cani Patrice D, De Vos Willem M, Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice, 10.1136/gutjnl-2017-314508
  29. Grander Christoph, Adolph Timon E, Wieser Verena, Lowe Patrick, Wrzosek Laura, Gyongyosi Benedek, Ward Doyle V, Grabherr Felix, Gerner Romana R, Pfister Alexandra, Enrich Barbara, Ciocan Dragos, Macheiner Sophie, Mayr Lisa, Drach Matthias, Moser Patrizia, Moschen Alexander R, Perlemuter Gabriel, Szabo Gyongyi, Cassard Anne Marie, Tilg Herbert, Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease, 10.1136/gutjnl-2016-313432
  30. Wu Wenrui, Lv Longxian, Shi Ding, Ye Jianzhong, Fang Daiqiong, Guo Feifei, Li Yating, He Xingkang, Li Lanjuan, Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model, 10.3389/fmicb.2017.01804
  31. Harte Alison L, da Silva Nancy F, Creely Steven J, McGee Kirsty C, Billyard Thomas, Youssef-Elabd Elham M, Tripathi Gyanendra, Ashour Esmat, Abdalla Mohga S, Sharada Hayat M, Amin Ashraf I, Burt Alastair D, Kumar Sudhesh, Day Christopher P, McTernan Philip G, Elevated endotoxin levels in non-alcoholic fatty liver disease, 10.1186/1476-9255-7-15
  32. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.-F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic Endotoxemia Initiates Obesity and Insulin Resistance, 10.2337/db06-1491
  33. Miele Luca, Valenza Venanzio, La Torre Giuseppe, Montalto Massimo, Cammarota Giovanni, Ricci Riccardo, Mascianà Roberta, Forgione Alessandra, Gabrieli Maria L., Perotti Germano, Vecchio Fabio M., Rapaccini Gianlodovico, Gasbarrini Giovanni, Day Chris P., Grieco Antonio, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, 10.1002/hep.22848
  34. Lassenius Mariann I., Pietiläinen Kirsi H., Kaartinen Kati, Pussinen Pirkko J., Syrjänen Jaana, Forsblom Carol, Pörsti Ilkka, Rissanen Aila, Kaprio Jaakko, Mustonen Jukka, Groop Per-Henrik, Lehto Markku, , Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation, 10.2337/dc10-2197
  35. Allin Kristine H., , Tremaroli Valentina, Caesar Robert, Jensen Benjamin A. H., Damgaard Mads T. F., Bahl Martin I., Licht Tine R., Hansen Tue H., Nielsen Trine, Dantoft Thomas M., Linneberg Allan, Jørgensen Torben, Vestergaard Henrik, Kristiansen Karsten, Franks Paul W., Hansen Torben, Bäckhed Fredrik, Pedersen Oluf, Aberrant intestinal microbiota in individuals with prediabetes, 10.1007/s00125-018-4550-1
  36. Wu Hao, Esteve Eduardo, Tremaroli Valentina, Khan Muhammad Tanweer, Caesar Robert, Mannerås-Holm Louise, Ståhlman Marcus, Olsson Lisa M, Serino Matteo, Planas-Fèlix Mercè, Xifra Gemma, Mercader Josep M, Torrents David, Burcelin Rémy, Ricart Wifredo, Perkins Rosie, Fernàndez-Real José Manuel, Bäckhed Fredrik, Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, 10.1038/nm.4345
  37. Dao Maria Carlota, Everard Amandine, Aron-Wisnewsky Judith, Sokolovska Nataliya, Prifti Edi, Verger Eric O, Kayser Brandon D, Levenez Florence, Chilloux Julien, Hoyles Lesley, Dumas Marc-Emmanuel, Rizkalla Salwa W, Doré Joel, Cani Patrice D, Clément Karine, , Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, 10.1136/gutjnl-2014-308778
  38. Scherbaum W. A., Schweizer A., Mari A., Nilsson P. M., Lalanne G., Jauffret S., Foley J. E., Efficacy and tolerability of vildagliptin in drug-nave patients with type 2 diabetes and mild hyperglycaemia, 10.1111/j.1463-1326.2008.00850.x
  39. Rosenstock, J., Rigby, S. P., Ford, D. M., Tao, B. & Chou, H. S. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes. Horm. Metab. Res. 46, 348–353 (2014).
  40. Kim Sin Gon, Kim Doo Man, Woo Jeong-Taek, Jang Hak Chul, Chung Choon Hee, Ko Kyung Soo, Park Jeong Hyun, Park Yong Soo, Kim Sang Jin, Choi Dong Seop, Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial, 10.1371/journal.pone.0092843
  41. Werner Maria, Tönjes Anke, Stumvoll Michael, Thiery Joachim, Kratzsch Jürgen, Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices, 10.1515/cclm.2008.020
  42. Borza Dana, Karmali Rafik, André Stéphanie, Valsamis Joseph, Cytryn Ephraim, Hermans Michel P., Beyer Ingo, Influence of assay-dependent variability of serum insulin levels on insulin sensitivity indices, 10.1515/cclm.2008.315
  43. Wallace T. M., Levy J. C., Matthews D. R., Use and Abuse of HOMA Modeling, 10.2337/diacare.27.6.1487
  44. Dennis John M., Shields Beverley M., Hill Anita V., Knight Bridget A., McDonald Timothy J., Rodgers Lauren R., Weedon Michael N., Henley William E., Sattar Naveed, Holman Rury R., Pearson Ewan R., Hattersley Andrew T., Jones Angus G., Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy, 10.2337/dc17-1827
  45. Vandeputte Doris, Kathagen Gunter, D’hoe Kevin, Vieira-Silva Sara, Valles-Colomer Mireia, Sabino João, Wang Jun, Tito Raul Y., De Commer Lindsey, Darzi Youssef, Vermeire Séverine, Falony Gwen, Raes Jeroen, Quantitative microbiome profiling links gut community variation to microbial load, 10.1038/nature24460
  46. Callahan Benjamin J, McMurdie Paul J, Rosen Michael J, Han Andrew W, Johnson Amy Jo A, Holmes Susan P, DADA2: High-resolution sample inference from Illumina amplicon data, 10.1038/nmeth.3869
  47. Wang Q., Garrity G. M., Tiedje J. M., Cole J. R., Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy, 10.1128/aem.00062-07
  48. Oksanen, J. B. et al. vegan: community ecology package. R package version 2.5-3 (2018).
  49. Gloor Gregory B., Reid Gregor, Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data, 10.1139/cjm-2015-0821
Bibliographic reference Depommier, Clara ; Everard, Amandine ; Druart, Céline ; Plovier, Hubert ; Van Hul, Matthias ; et. al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.. In: Nature medicine, Vol. 25, no.7, p. 1096-1103 (2019)
Permanent URL http://hdl.handle.net/2078.1/218911